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To function effectively, health systems require 
adequate financing; an effective workforce; 
reliable information for decision making; 
good governance; and available medicines 
and health technologies to deliver quality 
services to their populations.1 In low-income 
and middle-income countries (LMICs), 
health systems are often limited in this 
respect and fail to provide comprehensive 
population coverage of quality healthcare 
interventions. Health system strengthening 
comprises strategies to improve one or more 
of the functions of the health system in order 
to improve access, coverage, quality or effi-
ciency,1 and is recognised to be an essential 
step towards achieving universal coverage 
goals.2 Only when health systems function 
efficiently and effectively can they deliver 
services to meet population needs. The 
health system is recognised to be a complex 
and adaptive web of relationships and inter-
actions between people, institutions and 
resources, and the need for a complex adap-
tive systems approach to their evaluation has 
been recognised by researchers and policy 
makers.3 4 While the application of systems 
thinking to LMIC health systems is growing, 
this remains largely descriptive and quali-
tative in nature.5 In this paper, we begin by 
describing the growing importance of donor 
attention to health systems and resulting 
aid flows. We argue that current research 
methods are inadequate to accurately address 
donor needs: to demonstrate value for money 
for health systems relative to disease control 
programmes in a way that recognises and 
reflects the complexity of the health system 
and avoids reductionism; and to test system 
strengthening strategies in the lab, to under-
stand how they work and potential adverse 
events so as to optimise design. We argue that 
complexity science methods, and in particular 
system dynamics modelling (SDM) and agent-
based modelling (ABM), offer a promising 
means of effectively operationalising systems 
thinking to assess and maximise value for 
money for health systems programmes in 
LMICs.
In recognition of their importance, aid 
flows to health systems have been growing. 
Development assistance to health systems 
increased from US$ 540 million in 1990 to 
2.7 billion in 2015.6 Global health initiatives 
opened up funding streams to support health 
system strengthening in eligible countries 
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Summary box
 ► Health system strengthening is an essential step 
towards achieving universal coverage goals in 
low-income and middle-income countries  (LMICs). 
However, health systems are complex and health 
system strengthening initiatives are often introduced 
with limited understanding of how they will work in 
practice and the risk of potential adverse events
 ► Aid flows to health systems in LMICs have increased 
substantially in the last 15 years. Donors want to 
know whether their investments in health system 
strengthening represent value for money relative to 
disease control programmes and how to optimise 
the design of such programmes.
 ► Conventional evaluation methods ignore the 
complex dynamic nature of health systems and are 
insufficient to serve donor needs.
 ► System dynamics and agent-based modelling 
methods can reflect the complexity of health 
systems and be used to estimate value for money 
for health systems investments in LMICs and predict 
health system response to any stimulus prior to its 
introduction, including the detection of potential 
adverse events.
 ► There has been very limited application of system 
dynamics and agent-based modelling within the 
evaluation of health system strengthening initiatives 
in LMICs, and their future use by researchers is 
highly recommended.
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in the mid-2000s. In Global Fund Round 8 grants, for 
example, almost 40% of funds went to health system 
strengthening7, and around 10% of the Global Alli-
ance for Vaccines and Immunisation funds between 
2006 and 2013.8 These figures do not reflect the substantial 
sums that have been allocated by donors to interventions 
aimed at strengthening specific health system pillars (eg, 
financing, human resources). For example, results-based 
financing programmes, consisting of financial incentives 
for health workers, are operating in more than 30 LMICs, 
supported by US$ 1.6 billion in low-interest loans from 
the World Bank and US$ 410 million from the Results 
Innovation Trust Fund.
Increasingly, donor governments want to know 
whether their investments are paying off, and how much 
to invest in health systems relative to specific disease 
control programmes, and the relative impacts on popu-
lation health or value for money of each.9–11 Although 
important, this question risks pushing researchers away 
from a systems thinking perspective and towards isolating, 
quantifying and comparing the population-level effects 
of strategies aimed at strengthening a particular part of 
the system (eg, financing vs governance).10 Evaluations 
of health systems investments usually apply conventional 
methods to demonstrate programme effectiveness by 
measuring changes in patient and population outcomes 
(eg, ref 12 13). This is problematic as it treats the health 
system as static, one-dimensional, one-directional and 
linear.14 By their nature, health systems are, however, 
dynamic, multidimensional, non-linear and with feed-
back loops.15 16 The elements of a health system do not all 
respond simultaneously to a programme because there 
are inherent time delays associated with the progression 
of the programme effects through the system. There 
is communication between each of the health system 
elements or ‘pillars’ and feedback, the relationship is not 
unidirectional. Nor do elements operate independently 
of one another, for example, changes in financing 
arrangements will inevitably affect governance structures 
and human resources, which can in turn feedback and 
influence financing. Finally, the response of the health 
system is in general non-linear because the overall impact 
of two independent stimuli is not necessarily additive 
(the sum of the impacts of the two stimuli considered 
separately), it can be superadditive or subadditive.
Furthermore, the current emphasis and demand for 
evidence is focused on evaluation of interventions that 
have been implemented.3 Because strengthening the 
health system is generally perceived as a good, such 
programmes are often implemented in hospitals and 
clinics, impacting directly on health workers and patients, 
with very limited if any insight or understanding of how 
they will work and the risk of potential adverse events.17 
Yet for new drugs, pharmacological testing is required to 
understand the effect of the drug on the human body 
(pharmacodynamics), and to determine the required 
dosage, and monitor adverse events/safety, prior to 
clinical trials. Only once the mechanism of action is 
understood are efficacy studies carried out. While systems 
thinking approaches can be used to inform the design 
of programmes,3 18 typically no formal test of concept is 
carried out for health systems programmes, partly because 
their benefit is not questioned, and partly because of the 
absence of appropriate tools. Yet exploring the potential 
effects of programmes in the lab and testing responses to 
potential design changes before implementation would 
reduce the risk of adverse events in the real world, and 
further help to optimise design.
There are a variety of complexity science methods 
that can be used to unpack the complexity of healthcare 
systems in an LMIC setting, including network analysis, 
scenario planning and two mathematical modelling 
methods: SDM and ABM.19 Although all these methods 
can capture the complex static non-linear associations 
between elements of a complex system, only SDM20 and 
ABM21 22 can model dynamic system behaviour such as 
that observed within health systems.
ABM and SDM are well-known methods for modelling 
complex sociotechnical dynamic systems, including the 
dynamic behaviour of an accident and emergency depart-
ment23 24; accountable care organisations25; accountable 
care organisations25; policies to make care more afford-
able26; vaccine distribution systems27; and neonatal health 
policies28among many others (eg,  29). These models can 
be used to evaluate and quantify ex ante the response 
of a health system to any stimulus, including potential 
adverse events,30 be it for a new programme, or addi-
tional resources, a sudden disease outbreak or a natural 
disaster. The models would provide a computational 
experimental framework for optimising the perfor-
mance of a health system23 31 32 prior to in vivo testing 
of pilot programmes, and for enhancing the resilience 
of a health system to potential exogenous disturbances. 
Models can also be used to inform the design of subse-
quent empirical evaluations. System dynamics represents 
a top–down approach where the interest is in modelling 
the complex macrobehaviour of the system. ABM on the 
other hand is a bottom–up approach which is ideally 
suited to model emergent complex macrobehaviour which 
can only be deduced from modelling interactions at the 
microlevel between the different elements of the system 
(eg, health workers, healthcare managers and patients). 
Model structure can be informed by detailed descriptive 
mapping of processes and relationships between vari-
ables based on interviews or workshops and using tools 
such as causal loop diagrams and stock and flow diagrams 
in the case of system dynamics , or process mapping).33 
Empirical data are still needed for model calibration 
where available. Parameter estimates can also be derived 
through interviews with key stakeholders, from the liter-
ature or from data from other settings with appropriate 
adjustments. It is also important to carry out comprehen-
sive sensitivity analysis (deterministic or probabilistic) 
to evaluate the sensitivity of the outcomes of interest to 
the uncertainty in the parameter estimates. Each model-
ling approach has its advantages and disadvantages, and 
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the ideal approach for modelling a health system would 
depend on the specifics of the system and the nature of 
the programme under consideration, although the two 
approaches may also complement each other in under-
standing complex system behaviour.34
To date, there has been surprisingly limited appli-
cation of these methods within (ex ante or ex post) 
evaluation of health systems interventions in low-income 
and middle-income settings. In relation to other clas-
sical mathematical modelling methods (eg, statistical 
models), the use of ABM and SDM poses greater chal-
lenges to model validation.35 36 However, there is always 
a balance to strike between faithfully representing the 
real world with its complexity by using ABM and SDM 
and alternatively using simple modelling approaches 
that oversimplify system behaviour. These methods offer 
great potential to add new insights into the relative effec-
tiveness of health system strengthening compared with 
disease control programmes and to optimise design prior 
to implementation. We highly recommend their future 
use by researchers in this field.
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